This trial will study the outcomes of people who have had a robotic pancreaticoduodenectomy, which is a surgery to remove the pancreas and part of the small intestine.
1 Primary · 9 Secondary · Reporting Duration: QLQ-C30 will be measured at 2 to 4 weeks and 3 to 6 months-post intervention.
Active Control
Experimental Treatment
81 Total Participants · 3 Treatment Groups
Primary Treatment: minimally invasive pancreaticoduodenectomy · No Placebo Group · N/A
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: